Announcements Trials
Browse Landscape

Phase

Phase NA 31Phase 3 4Phase 2 2Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Unilateral U/S PVB 1Stomach Neoplasms 1Pain, Postoperative 1Lung Neoplasms 1Liver Neoplasms 1Liver Diseases 1Head and Neck Neoplasms 1Epstein-Barr Virus Infections 1Diarrhea 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Letrozole 20Docetaxel 16Cyclophosphamide 13Zoledronic Acid 12exemestane 11Trastuzumab 11Anastrozole 11Paclitaxel 10Tamoxifen 9Capecitabine 9Fulvestrant 8Epirubicin 8pegfilgrastim 7pertuzumab 6liposomal doxorubicin 6abemaciclib 6Saline Solution 6palbociclib 5Sodium Chloride 5Dexmedetomidine 5Carboplatin 5Bupivacaine 5Bevacizumab 5ribociclib 4pegylated granulocyte colony-stimulating factor 4eribulin 4Tranexamic Acid 4Standard of Care 4Pamidronate 4Filgrastim 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Breast Neoplasms × Control Groups × Clear all
NCT04904653 2024-03-06

The Effectiveness of Hemopatch® in the Reduction of Post-surgical Serous Drainage

Instituto de Investigación Hospital Universitario La Paz

Phase 4 Unknown
118 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡